Company Inovio Pharmaceuticals Inc Nyse
Equities
INO
US45773H2013
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
DNA Medicines
100.0
%
| 10 | 100.0 % | 1 | 100.0 % | -91.89% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 10 | 100.0 % | 1 | 100.0 % | -91.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 24/03/19 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 31/05/02 |
Chief Tech/Sci/R&D Officer | - | 31/01/07 | |
Jeffrey Skolnik
CTO | Chief Tech/Sci/R&D Officer | - | 11/10/16 |
Michael Sumner
CTO | Chief Tech/Sci/R&D Officer | 59 | 26/06/22 |
Laurent Humeau
CTO | Chief Tech/Sci/R&D Officer | 57 | 17/02/14 |
Thomas Hong
IRC | Investor Relations Contact | - | - |
Cheryl Elder
LAW | General Counsel | - | - |
Shawn D. Bridy
PRN | Corporate Officer/Principal | - | 23/05/18 |
Maggie Campbell
AUD | Comptroller/Controller/Auditor | - | 28/02/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 30/11/03 |
Lota Zoth
BRD | Director/Board Member | 64 | 31/12/17 |
Jay Shepard
BRD | Director/Board Member | 65 | 14/01/20 |
Wendy Yarno
BRD | Director/Board Member | 69 | 05/12/17 |
David Weiner
FOU | Founder | 67 | 28/06/83 |
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 24/03/19 |
Roger Dansey
BRD | Director/Board Member | 68 | 12/05/21 |
Ann Miller
BRD | Director/Board Member | 66 | 24/03/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,091 | 0 | 1,082 ( 99.18 %) | 98.51 % |
Stock B | 1 | 25,329,333 | 24,953,826 ( 98.52 %) | 0 |
Company contact information
Inovio Pharmaceuticals, Inc.
660 West Germantown Pike Suite 110
19462-1111, Plymouth Meeting
+267 440 4200
http://www.inovio.comSector
1st Jan change | Capi. | |
---|---|---|
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |